Waverley Pharma (TSE:WAVE) has released an update.
Waverley Pharma Inc., a Canadian pharmaceutical company, has announced the purchase of C&R Pharmacy, an Ohio-based independent pharmacy, for $450,000 with potential additional performance-based payments. This strategic acquisition aligns with Waverley’s drug development focus but offers immediate revenue and opportunities for future growth. The company plans to fund the acquisition using its existing working capital.
For further insights into TSE:WAVE stock, check out TipRanks’ Stock Analysis page.
